FIELD: medicine. SUBSTANCE: method involves taking patient lymph sample before operation from thoracic lymphatic duct, separating lymph plasma from its formed elements. The separated lymph plasma is used as solvent for dissolving chemical preparations and the so produced solution is to be administered to the patient as injections. EFFECT: reduced toxic effect of the administered preparations; increased operability rate.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING CANCER | 1998 |
|
RU2154487C2 |
| METHOD FOR TREATING THE CANCER | 1998 |
|
RU2188656C2 |
| METHOD FOR TREATING PULMONARY CANCER | 1993 |
|
RU2107494C1 |
| METHOD FOR COMPLEX THERAPY OF PULMONARY CANCER. | 2003 |
|
RU2257218C1 |
| METHOD FOR CANCER TREATMENT IN CHILDREN | 2002 |
|
RU2239440C2 |
| METHOD OF TREATMENT OF PATIENTS WITH LUNG CANCER | 1995 |
|
RU2123342C1 |
| METHOD FOR TREATING CANCER OF UTERINE BODY | 2000 |
|
RU2195268C2 |
| METHOD FOR TREATING INOPERABLE PULMONARY CANCER | 2003 |
|
RU2257233C2 |
| METHOD FOR TREATING CANCER | 2005 |
|
RU2290933C1 |
| METHOD FOR PREOPERATIVE TREATMENT OF RECTUM CANCER | 1993 |
|
RU2085200C1 |
